List of Chapters/Sections(Table Of Content)
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Lysis & Disruption Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Mammalian cells
1.2.3 Bacterial cells
1.2.4 Yeast/Algae/Fungi
1.2.5 Plant cells
1.3 Market by Application
1.3.1 Global Cell Lysis & Disruption Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Protein Isolation
1.3.3 Downstream Processing
1.3.4 Cell Organelle Isolation
1.3.5 Nucleic Acid Isolation
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cell Lysis & Disruption Market Perspective (2017-2028)
2.2 Cell Lysis & Disruption Growth Trends by Region
2.2.1 Cell Lysis & Disruption Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cell Lysis & Disruption Historic Market Size by Region (2017-2022)
2.2.3 Cell Lysis & Disruption Forecasted Market Size by Region (2023-2028)
2.3 Cell Lysis & Disruption Market Dynamics
2.3.1 Cell Lysis & Disruption Industry Trends
2.3.2 Cell Lysis & Disruption Market Drivers
2.3.3 Cell Lysis & Disruption Market Challenges
2.3.4 Cell Lysis & Disruption Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Lysis & Disruption Players by Revenue
3.1.1 Global Top Cell Lysis & Disruption Players by Revenue (2017-2022)
3.1.2 Global Cell Lysis & Disruption Revenue Market Share by Players (2017-2022)
3.2 Global Cell Lysis & Disruption Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell Lysis & Disruption Revenue
3.4 Global Cell Lysis & Disruption Market Concentration Ratio
3.4.1 Global Cell Lysis & Disruption Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Lysis & Disruption Revenue in 2021
3.5 Cell Lysis & Disruption Key Players Head office and Area Served
3.6 Key Players Cell Lysis & Disruption Product Solution and Service
3.7 Date of Enter into Cell Lysis & Disruption Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Lysis & Disruption Breakdown Data by Type
4.1 Global Cell Lysis & Disruption Historic Market Size by Type (2017-2022)
4.2 Global Cell Lysis & Disruption Forecasted Market Size by Type (2023-2028)
5 Cell Lysis & Disruption Breakdown Data by Application
5.1 Global Cell Lysis & Disruption Historic Market Size by Application (2017-2022)
5.2 Global Cell Lysis & Disruption Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cell Lysis & Disruption Market Size (2017-2028)
6.2 North America Cell Lysis & Disruption Market Size by Country (2017-2022)
6.3 North America Cell Lysis & Disruption Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Cell Lysis & Disruption Market Size (2017-2028)
7.2 Europe Cell Lysis & Disruption Market Size by Country (2017-2022)
7.3 Europe Cell Lysis & Disruption Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Lysis & Disruption Market Size (2017-2028)
8.2 Asia-Pacific Cell Lysis & Disruption Market Size by Country (2017-2022)
8.3 Asia-Pacific Cell Lysis & Disruption Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Cell Lysis & Disruption Market Size (2017-2028)
9.2 Latin America Cell Lysis & Disruption Market Size by Country (2017-2022)
9.3 Latin America Cell Lysis & Disruption Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Lysis & Disruption Market Size (2017-2028)
10.2 Middle East & Africa Cell Lysis & Disruption Market Size by Country (2017-2022)
10.3 Middle East & Africa Cell Lysis & Disruption Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Thermo Fisher Scientific, Inc. Company Detail
11.1.2 Thermo Fisher Scientific, Inc. Business Overview
11.1.3 Thermo Fisher Scientific, Inc. Cell Lysis & Disruption Introduction
11.1.4 Thermo Fisher Scientific, Inc. Revenue in Cell Lysis & Disruption Business (2017-2022)
11.1.5 Thermo Fisher Scientific, Inc. Recent Development
11.2 Merck KGaA
11.2.1 Merck KGaA Company Detail
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Cell Lysis & Disruption Introduction
11.2.4 Merck KGaA Revenue in Cell Lysis & Disruption Business (2017-2022)
11.2.5 Merck KGaA Recent Development
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Company Detail
11.3.2 F. Hoffmann-La Roche Ltd Business Overview
11.3.3 F. Hoffmann-La Roche Ltd Cell Lysis & Disruption Introduction
11.3.4 F. Hoffmann-La Roche Ltd Revenue in Cell Lysis & Disruption Business (2017-2022)
11.3.5 F. Hoffmann-La Roche Ltd Recent Development
11.4 Qiagen NV
11.4.1 Qiagen NV Company Detail
11.4.2 Qiagen NV Business Overview
11.4.3 Qiagen NV Cell Lysis & Disruption Introduction
11.4.4 Qiagen NV Revenue in Cell Lysis & Disruption Business (2017-2022)
11.4.5 Qiagen NV Recent Development
11.5 Becton Dickinson & Company (BD)
11.5.1 Becton Dickinson & Company (BD) Company Detail
11.5.2 Becton Dickinson & Company (BD) Business Overview
11.5.3 Becton Dickinson & Company (BD) Cell Lysis & Disruption Introduction
11.5.4 Becton Dickinson & Company (BD) Revenue in Cell Lysis & Disruption Business (2017-2022)
11.5.5 Becton Dickinson & Company (BD) Recent Development
11.6 Danaher Corporation
11.6.1 Danaher Corporation Company Detail
11.6.2 Danaher Corporation Business Overview
11.6.3 Danaher Corporation Cell Lysis & Disruption Introduction
11.6.4 Danaher Corporation Revenue in Cell Lysis & Disruption Business (2017-2022)
11.6.5 Danaher Corporation Recent Development
11.7 Bio-Rad Laboratories, Inc.
11.7.1 Bio-Rad Laboratories, Inc. Company Detail
11.7.2 Bio-Rad Laboratories, Inc. Business Overview
11.7.3 Bio-Rad Laboratories, Inc. Cell Lysis & Disruption Introduction
11.7.4 Bio-Rad Laboratories, Inc. Revenue in Cell Lysis & Disruption Business (2017-2022)
11.7.5 Bio-Rad Laboratories, Inc. Recent Development
11.8 Miltenyi Biotec GmbH
11.8.1 Miltenyi Biotec GmbH Company Detail
11.8.2 Miltenyi Biotec GmbH Business Overview
11.8.3 Miltenyi Biotec GmbH Cell Lysis & Disruption Introduction
11.8.4 Miltenyi Biotec GmbH Revenue in Cell Lysis & Disruption Business (2017-2022)
11.8.5 Miltenyi Biotec GmbH Recent Development
11.9 Claremont BioSolutions, LLC
11.9.1 Claremont BioSolutions, LLC Company Detail
11.9.2 Claremont BioSolutions, LLC Business Overview
11.9.3 Claremont BioSolutions, LLC Cell Lysis & Disruption Introduction
11.9.4 Claremont BioSolutions, LLC Revenue in Cell Lysis & Disruption Business (2017-2022)
11.9.5 Claremont BioSolutions, LLC Recent Development
11.10 Microfluidics International Corporation
11.10.1 Microfluidics International Corporation Company Detail
11.10.2 Microfluidics International Corporation Business Overview
11.10.3 Microfluidics International Corporation Cell Lysis & Disruption Introduction
11.10.4 Microfluidics International Corporation Revenue in Cell Lysis & Disruption Business (2017-2022)
11.10.5 Microfluidics International Corporation Recent Development
11.11 Parr Instrument Company
11.11.1 Parr Instrument Company Company Detail
11.11.2 Parr Instrument Company Business Overview
11.11.3 Parr Instrument Company Cell Lysis & Disruption Introduction
11.11.4 Parr Instrument Company Revenue in Cell Lysis & Disruption Business (2017-2022)
11.11.5 Parr Instrument Company Recent Development
11.12 BioVision, Inc.
11.12.1 BioVision, Inc. Company Detail
11.12.2 BioVision, Inc. Business Overview
11.12.3 BioVision, Inc. Cell Lysis & Disruption Introduction
11.12.4 BioVision, Inc. Revenue in Cell Lysis & Disruption Business (2017-2022)
11.12.5 BioVision, Inc. Recent Development
11.13 Covaris, Inc.
11.13.1 Covaris, Inc. Company Detail
11.13.2 Covaris, Inc. Business Overview
11.13.3 Covaris, Inc. Cell Lysis & Disruption Introduction
11.13.4 Covaris, Inc. Revenue in Cell Lysis & Disruption Business (2017-2022)
11.13.5 Covaris, Inc. Recent Development
11.14 Qsonica LLC
11.14.1 Qsonica LLC Company Detail
11.14.2 Qsonica LLC Business Overview
11.14.3 Qsonica LLC Cell Lysis & Disruption Introduction
11.14.4 Qsonica LLC Revenue in Cell Lysis & Disruption Business (2017-2022)
11.14.5 Qsonica LLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
